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1. Introduction
   The electrocardiogram (ECG) is one of the most commonly 
done and readily available cardiovascular diagnostic tests. It 
is the test most often done for a patient with chest pain. The 
ECG is also used for monitoring patients in high dependency 
wards and intensive care units, for pre-operative screening 
and even in health screening assessments for individuals in 
certain high risk occupations[1-3].
  Due to the wide applications of the ECG, the interpretation 
is also critical. These days, with advances in technology, 
electronic and computerised systems are more readily 
available for storage as well as interpretation of ECGs. 
Patients previous ECGs stored in the database or 
electronic archive systems, serve as a valuable resource 
as baseline comparison to the current ECG and can play 
a role in clinical decision making and management of the 
patient with acute chest presentations in the Emergency 
Department (ED)[1,2].
  There are many causes for the acute chest pain that makes 
a person presents to the ED. Causes include both cardiac 
and non-cardiac etiologies. Some examples of the latter 
include, oesophageal spasm, gastric pain, pleuritic chest 
pain, costo-chondritis and musculo-skeletal chest pain. 
The ECG has been used for decades to help differentiate 
between both types of etiologies, but we do know now that 
this is not always possible. 
  There are patients with acute coronary syndrome who do 
not manifest any overt ECG changes. There are also patients 
whose ECG changes were not present on the first presenting 
ECG, but developed much later on and was detected by the 
performance of serial ECGs or continuous ST-segment trend 
monitoring. The 12-lead ECG does not always show overt 
changes to diagnose acute coronary syndrome (ACS)[4-7]. 
  Coronary artery disease (CAD) remains an important 
cause of morbidity and mortality worldwide[1,4,5,7]. Many 
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patients with underlying CAD and heart failure may have 
a combination of both viable and non-viable myocardium. 
Many are now beginning to realise that it is important and 
relevant to be able to differentiate viable from non viable 
myocardium[8-10]. However the picture is complicated 
because of the phenomenon of myocardial stunning (where 
the viable myocardium is non contractile or dysfunctional in 
contraction, for a variable period of time, but is reversible, 
often after reperfusion) and myocardial hibernation 
(ischaemic myocardium , usually supplied by a narrowed 
coronary vessel, in which these ischaemic myocardial cells 
continue to remain viable , but contraction is chronically 
depressed)[8,11-13]. 
  This paper postulates a quick and relatively easy way 
to quantify the mass of viable myocardium in patients 
presenting with acute chest pain in the ED. This is done by 
integrating the QRS complex of an ECG to obtain the area 
under the QRS complex, which can quantify the mass of 
viable myocardium. 
  The quantifiable difference in the size of the area of the 
QRS complex of the current ECG, compared to an earlier 
ECG obtained from the same patient on a prior occasion may 
show change in the mass (gain or loss) of viable myocardium 
in the patient’s heart over a period of time. 
  Therefore if there is a loss or decrease in the mass of viable 
myocardium, there could possibly be a new ischaemic event 
such as ACS or infarction, that has taken place between the 
time the two ECGs were done. The comparison of the area 
under the QRS complex can be assessed either visually 
or quantitatively and the comparison must be done using 
identical leads.  
2. Methodology
  The area under the QRS complex of a patient’s ECG 
is postulated to be proportional to the amount of viable 
myocardium. If a patient suffers a myocardial infarction 
and the myocardium loses its viability (i.e. the ability to 
‘fire’ or depolarise and repolarise), the area under the QRS 
complex is reduced. By comparing the areas under the QRS 
complexes at two different times (e.g. T=0 and T=1) for the 
same patient, a reduction of the area represents a loss of the 
viable myocardium. Determining the difference may be done 
either visually or quantitatively (Figure 1).  
Figure 1. Area under the curve of the QRS complex.
 
3. Results
  In a retrospective analysis of 42 ECG tracings belonging 
to 10 patients with acute myocardial infarction, with a 
mean age of 64 years and diagnosed by board certified 
cardiologists to have sustained ischaemic insults, visual 
inspection of the area under the QRS complex, obtained 
by utilising lead V2, showed that the areas on the follow up 
ECGs have all been reduced by varying degrees.  Further 
calculation performed showed the reduction, on average to 
be 36.7% (Max: -83.9%, Min: -1.3%) (Figure 2) 
Figure 2. Percentage of reduction of the area under the QRS complex 
after AMI.
4. Discussion
  This novel method utilises the fact that viable myocardial 
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cells will contribute towards cardiac contraction. 
Myocardial viability is a binary phenomenon: segments of 
the myocardium or heart muscles are either viable or not 
because of the all or none property of an excitable cell. 
The QRS complex is recorded on the ECG tracing when the 
heart is undergoing ventricular depolarization. When the 
myocardial cells have suffered an ischaemic insult, they 
become non-viable and thus cannot ‘fire’ (i.e. depolarise 
and repolarise) and hence this is postulated to affect the 
appearance and manifestation/morphology of the QRS 
complex.
  With the advent and more widespread use of digital ECGs, 
it may be possible to consider incorporating this capability 
into the machine software and technology. Further work will 
be required to ensure a more robust validation technique 
and corroboration of the results in a larger cohort study.
  This novel technique proposed shows high potential 
for practical application and more work in the form of 
prospective validation. Software trial in a larger cohort 
could help prove convincingly that the area under the QRS 
complex of the ECG reflects myocardial viability and any 
ischaemic insults/infarction will result in a reduction of the 
area of a subsequent ECG in any patient. 
  It will also be useful in the future study to correlate this 
with other parameters which are currently used to assess 
viability, such as the calculated ejection fraction or MIBI 
scan findings[12-14]. This novel proposed method provides an 
option to be used in time-critical AMI diagnosis, when ECG 
changes are less clear, history is not suggestive or in silent 
AMI, whilst waiting for the cardiac markers to come back 
from the laboratory.
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